Tick saliva may be a secret ingredient to help HIV patients

September 7, 2017 by Jill Daly, Pittsburgh Post-Gazette
HIV infecting a human cell. Credit: NIH

The black-legged tick -loaded with bacteria causing Lyme disease - may have some good qualities: its spit.

Tick saliva - the same fluid that sets the stage for feeding on their hosts by blocking blood coagulation - is now part of experiments examining ways to reduce heart disease in people living with HIV. Their risk of heart attack and stroke is nearly double that of the general population, according to a study last year. That risk was found even in people whose virus is undetectable in their blood because of .

Chronic inflammation is suspected as the cause of the cardiovascular disease, and researchers in the HIV field are trying to find out what causes it, according to Ivona Pandrea, professor of pathology in the Center for Vaccine Research at the University of Pittsburgh.

Although HIV patients are treated with antiretroviral drugs and the virus is well controlled, Pandrea said, "Patients develop other issues, comorbidities that affect organs and systems that reduce longevity. They develop health problems that old people have. The aging process is accelerated in HIV patients. The main cause is inflammation."

Pandrea is co-senior author of recently published research that says the increased can be linked to an overabundance of a type of immune cell in people with HIV.

Irini Sereti, of the National Institute of Allergy and Infectious Diseases, was also co-senior author, and her team found that in human blood samples, people with HIV share an elevated number of the immune cells called monocytes that continue to express a protein that triggers blood clotting and inflammation even if the HIV virus is under control.

Pandrea found the same cells in monkeys that progress to AIDS after infection with SIV, the primate form of HIV. The cells taken from a different species of monkey, which usually doesn't develop when infected with SIV, didn't express the protein involved with clotting and inflammation.

As reported in Science Translational Medicine last week, the human blood samples were exposed to Ixolaris, a synthetic version of the small molecule found in the saliva of the tick (scientific name: Ixodes scapularis), and the team found the protein activity was blocked. Then a small group of lab monkeys, including the two different species and both with an early infection of SIV, were treated with the drug.

"Both models replicated very well the virus," Pandrea said, "but one did not have hypercoagulation; the other had high coagulation and high ." The levels of the inflammatory proteins in the high-coagulation species were lowered with the Ixolaris treatment.

The study concluded that "targeting the coagulation pathway in HIV-infected patients may be effective in reducing the immune activation and inflammation that are linked to cardiovascular comorbidities in HIV infection." It may also help as therapy in other inflammatory diseases, the study said.

NIH holds the patent for Ixolaris, which in the past was tested to treat blood clots in animals. More work needs to be done to confirm the research findings and study the effectiveness and safety of treatment with Ixolaris, Pandrea said.

The study is a step forward. She said, "It's about a new cause of inflammation in the HIV patient: hypercoagulation. It establishes a clear connection with hypercoagulation and ."

Tick saliva alone won't do the trick, however:

"I wouldn't recommend people getting bitten by ticks. They'll still get Lyme disease."

Explore further: Tick saliva may hold potential treatment for reducing HIV-linked heart disease risk

Related Stories

Tick saliva may hold potential treatment for reducing HIV-linked heart disease risk

August 30, 2017
Scientists may have found a clue to why people living with HIV have double the likelihood of developing heart disease. The findings, made by researchers at the University of Pittsburgh Center for Vaccine Research and National ...

Breakthrough in HIV/AIDS research gives hope for improved drug therapy

May 16, 2014
The first direct proof of a long-suspected cause of multiple HIV-related health complications was recently obtained by a team led by the University of Pittsburgh Center for Vaccine Research (CVR). The finding supports complementary ...

High-fat diet leads to same intestinal inflammation as a virus

June 22, 2017
A new study by scientists at UCLA found that when mice eat a high-fat diet, the cells in their small intestines respond the same way they do to a viral infection, turning up production of certain immune molecules and causing ...

A tick's spit leads to an entire lesson in blood clotting

July 1, 2013
There really is such a thing as tick spit – that is, the saliva of a tick. And there's something about it that might help fight heart disease and stroke.

Recommended for you

Green leafy vegetables may prevent liver steatosis

December 17, 2018
A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake ...

Discovery of novel mechanisms that cause migraines

December 17, 2018
Researchers at CNRS, Université Côte d'Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. They found how a mutation that causes dysfunction in a protein which inhibits neuronal electrical ...

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.